参考文献
[1]Chesson H W,Dunne E F,Hariri S,et al.The estimated lifetime probability of acquiring human papillomavirus in the United States[J].Sex Transm Dis,2014,41(11):660-664.
[2]Schiffman M,Castle P E.Human papillomavirus:epidemiology and public health[J].Arch Pathol Lab Med,2003,127(8):930-934.
[3]Thomas D B,Ray R M,Koetsawang A,et al.Human papillomaviruses and cervical cancer in Bangkok.I.Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA[J].Am J Epidemiol,2001,153(8):723-731.
[4]Khan M J,Castle P E,Lorincz A T,et al.The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus(HPV)type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice[J].J Natl Cancer Inst,2005,97(14):1072-1079.
[5]Bruni L,Diaz M,CastellsaguéX,et al.Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytological findings[J].J Infect Dis,2010,202(12):1789-1799.
[6]Guan P,Howell-Jones R,Li N,et al.Human papillomavirus types in 115,789 HPV-positive women:a meta-analysis from cervical infection to cancer[J].Int J Cancer,2012,131(10):2349-2359.
[7]De Sanjose S,Quint W G,Alemany L,et al.Human papillomavirus genotype attribution in invasive cervical cancer:a retrospective cross-sectional worldwide study[J].Lancet Oncol,2010,11(11):1048-1056.
[8]Wu E Q,Liu B,Cui J F,et al.Prevalence of type-specific human papillomavirus and pap results in Chinese women:a multi-center,population-based cross-sectional study[J].Cancer Causes Control,2013,24(4):795-803.
[9]Chen W,Zhang X,Molijn A,et al.Human papillomavirus type-distribution in cervical cancer in China:the importance of HPV 16 and 18[J].Cancer Causes Control,2009,20(9):1705-1713.
[10]Doorbar J,Quint W,Banks L,et al.The biology and life-cycle of human papillomaviruses[J].Vaccine,2012,30(5):55-70.
[11]Pinidis P,Tsikouras P,Iatrakis G,et al.Human Papilloma Virus'Life Cycle and Carcinogenesis[J].Maedica(Bucur),2016,11(1):48-54.
[12]Kaderli R,Schnüriger B,Brügger L E.The impact of smoking on HPV infection and the development of anogenital warts[J].Int J Colorectal Dis,2014,29(8):899-908.
[13]Elfgren K,Kalantari M,Moberger B,et al.A population-based five-year follow-up study of cervical human papillomavirus infection[J].Am J Obstet Gynecol,2000,183(3):561-567.
[14]Torre L A,Bray F,Siegel R L,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
[15]Lax S F,Horn L C,Löning T.Categorization of uterine cervix tumors:What's new in the 2014 WHO classification[J].Pathologe,2016,37(6):573-584.(https://www.daowen.com)
[16]Artacho-Pérula E,Roldán-Villalobos R,Salas-Molina J,et al.Multivariate discriminant analysis of normal,intraepithelial neoplasia and human papillomavirus infection of the uterine cervix samples[J].Histol Histopathol,1994,9(1):135-140.
[17]Cleveland A A,Gargano J W,Park I U,et al.Cervical adenocarcinoma in situ:Human papillomavirus types and incidence trends in five states,2008-2015[J].Int J Cancer,2020,146(3):810-818.
[18]Ostör A G.Natural history of cervical intraepithelial neoplasia:a critical review[J].Int J Gynecol Pathol,1993,12(2):186-192.
[19]Basu P,Mittal S,Bhadra Vale D,et al.Secondary prevention of cervical cancer[J].Best Pract Res Clin Obstet Gynaecol,2018,47:73-85.
[20]Wong O G,Ho M W,Tsun O K,et al.An automated quantitative DNA image cytometry system detects abnormal cells in cervical cytology with high sensitivity[J].Cytopathology,2018,29(3):267-274.
[21]Nguyen V Q,Grote H J,Pomjanski N,et al.Interobserver reproducibility of DNA-image-cytometry in ASC-US or higher cervical cytology[J].Cell Oncol,2004,26(3):143-150.
[22]Bollmann R,Méhes G,Speich N,et al.Aberrant,highly hyperdiploid cells in human papillomavirus-positive,abnormal cytologic samples are associated with progressive lesions of the uterine cervix[J].Cancer,2005,105(2):96-100.
[23]梅金红,徐姗,韩永良,等.不能明确意义的不典型鳞状细胞伴DNA倍体异常在宫颈早期病变筛查中的意义[J].中华病理学杂志,2013,42(12):829-932.
[24]Silva D C,Gonçalves A K,Cobucci R N,et al.Immunohistochemical expression of p16、Ki-67 and p53 in cervical lesions-A systematic review[J].Pathol Res Pract,2017,213(7):723-729.
[25]Packet B,Poppe W,Weynand B,et al.The use of p16、Ki-67 dual staining technology on cervical cytology of patients undergoing a LLETZ procedure[J].Eur J Obstet Gynecol Reprod Biol,2018,228:191-196.
[26]Wright T C,Jr.,Behrens C M,Ranger-Moore J,et al.Triaging HPV-positive women with p16、Ki-67 dual-stained cytology:Results from a sub-study nested into the ATHENA trial[J].Gynecol Oncol,2017,144(1):51-56.
[27]黄平,张雪,陈光元,等.宫颈脱落细胞HPV L1蛋白监测在高危型HPV阳性妇女分流中的应用[J].海南医学,2016,27(20):3322-3324.
[28]Yang W,Lu Y P,Yang Y Z,et al.Expressions of programmed death(PD)-1 and PD-1 ligand(PD-L1)in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status[J].J Obstet Gynaecol Res,2017,43(10):1602-1612.
[29]Dabeski D,Duvlis S,Basheska N,et al.Comparison Between HPV-DNA Testing and HPV E6/E7 m RNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix[J].Pril(Makedon Akad Nauk Umet Odd Med Nauki),2019,40(1):51-58.
[30]Macedo A C L,Bavaresco D V,Gonçalves J C N,et al.Accuracy of Messenger RNA human papillomavirus Tests for Diagnostic Triage of Minor Cytological Cervical Lesions:A Systematic Review and Meta-Analysis[J].Sex Transm Dis,2019,46(5):297-303.